BOLETÍN HTA

47 Boletín Hipertensión VOL 23. 2019 / 40 - 47 Estudio CORAL 8. Weinberg MD, Olin JW. Stenting for atherosclerotic renal ar- tery stenosis: one poorly designed trial after another. Cleve Clin J Med 2010;77:164-71. 9. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon an- gioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? Ameta-analysis of ran- domized controlled trials. The American journal of medicine 2003;114:44-50. 10. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atheros- clerotic renovascular disease: ameta-analysis of randomized trials. Nephrology, dialysis, transplantation : official publica- tion of theEuropeanDialysis and Transplant Association - Eu- ropean Renal Association 2003;18:298-304. 11. Murphy TP, Cooper CJ, Dworkin LD, et al. The Cardiovascular OutcomeswithRenal Atherosclerotic Lesions (CORAL) Study: Rationale and Methods. Journal of Vascular and Interventio- nal Radiology 2005;16:1295-300. 12. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascula- rization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hyper- tension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66. 13. Murphy TP, Cooper CJ, Pencina KM, et al. Relationship of Al- buminuria and Renal Artery Stent Outcomes. Hypertension 2016;68:1145-52. 14. Murphy TP, Cooper CJ, Matsumoto AH, et al. Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient. Journal of the American College of Cardiology 2015;66:2487-94. 15. Cooper EL, Xie Y, Nguyen H, et al. Early Rapid Decline in Kid- ney Function inMedically Managed PatientsWith Atheroscle- rotic Renal Artery Stenosis. Journal of the American Heart Association 2019;8:e012366. 16. Muray S, Martín M Fau - Amoedo ML, Amoedo Ml Fau - Gar- cíaC, et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery ste- nosis. Am J Kidney Dis 2002;39:60-6. 17. TuttleKR, DworkinLD, HenrichW, et al. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predic- tors of Clinical Events in the CORAL Trial. Clinical Journal of the American Society of Nephrology 2016;11:1180-8. 18. Cohen JB, Townsend RR. Use of renin-angiotensin system blockade in patients with renal artery stenosis. Clin J AmSoc Nephrol 2014;9:1149-52. 19. Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupa- ttelli L. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrology Dialy- sis Transplantation 2005;20:1604-9. 20. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Gui- deline for the Prevention, Detection, Evaluation, and Mana- gement of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:e13-e115. 21. Aboyans V, Ricco J-B, Bartelink M-LEL, et al. 2017 ESC Gui- delines on the Diagnosis and Treatment of Peripheral Arte- rial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European Heart Journal 2017;39:763-816.